Chennai

Siddha Central Research Institute (SCRI) is identified as a potential centre of excellence for clinical research. This Institute is located in the campus of  Anna Government Hospital of Indian systems of  Medicine and Homoeopathy at Arumbakkam,  Chennai. Central Research Institute for Siddha was established in the year 1971. It has all the facilities for preclinical and clinical studies.

Janssen India, the pharmaceutical division of Johnson & Johnson India, is dedicated to addressing and solving some of the most important unmet medical needs of our time in India, in oncology, immunology, neuroscience and analgesia, dermatology, infectious diseases and metabolic diseases. Driven by a strong dedication to the health and well-being of patients, Janssen India brings innovative products, services and solutions to people throughout the world.  

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. With our patients at the centre of all that we do, we help to accelerate the development of drugs and devices that save lives and improve quality of life. Our people are our greatest strength, are at the core of our culture, and the driving force behind our success.

Central Council for Research in Siddha (CCRS) under Ministry of Ayush is an apex body for conducting research in Siddha system of medicine and provides health care facilities through its 8 peripheral institutes / units and 5 co-located units of CCRS. The Council is engaged in multifaceted research activities. In the area of clinical research, pre-clinical Pharmacological / Toxicological studies, Open label trials, multi-centric Randomized Controlled Trials (RCTs) are being conducted for acute and chronic diseases.